Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39393406 for Smoking Cessation
NCT02217527Phase 2Completed
- Start
- Nov 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-39393406 in nicotine dependence. Started Nov 2014; status: completed.
02
Drugs
JNJ-39393406
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02217527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217527.